First commercial production in Biocatalysts’ new enzyme manufacturing facility
date:May 21, 2021
and 10,000L and has been designed to accommodate future growth.

The whole process is controlled by state-of-the-art Siemens software to maximise capacity and enhance efficiencies, guaranteeing world-class support and service.

Coupled with its award-winning enzyme discovery, development and manufacturing process Biocatalysts Ltd truly have a unique breadth of offering in the biotechnology marketplace.

Craig Galeozzie, Director of Operations at Biocatalysts Ltd, commented: The strategic plannin
3/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/16 10:36